P
Peak Bggradded this to Biotech Investing
Novo Nordisk: Solid Performance Marred By Currency Fluctuations

Novo Nordisk: Solid Performance Marred By Currency Fluctuations

Seeking Alpha - Power Hedge

On Friday, February 1, 2019, Danish diabetes-focused pharmaceutical giant Novo Nordisk (NVO) announced its fourth quarter 2018 earnings results. At …

View on seekingalpha.com